IP Library › Assignment 057388/0622
Patent Assignment
Reel/Frame 057388/0622

Certificate of Conversion

Recorded: 2021-07-22 Pages: 21
Assignor
KV1.3 THERAPEUTICS, LLC
Executed: 2017-10-11
Assignee
KV1.3 THERAPEUTICS, INC.
219 TERRY AVENUE NORTH, SUITE 300, SEATTLE, WASHINGTON, 98109
Covered Property (1)
TREATMENT OF OBESITY AND OBESITY RELATED DISORDERS BY PHARMACOLOGICAL TARGETING OF Kv1.3 POTASSIUM CHANNELS
Patent: 9,878,006 →
Application: 15/049,353 →
Publication: US 2017/0095530
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 5, 2016
From: CHANDY, K. GEORGE; UPADHAYAY, SANJEEV KUMAR; WANG, PING H.; SASSONE-CORSI, PAOLO
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 040531/0088 →
Assignment of Assignor's Interest Dec 5, 2016
From: IADONATO, SHAWN
To: KINETA ONE, LLC
Reel/Frame 040531/0128 →
Assignment of Assignor's Interest Jul 22, 2021
From: KV1.3 THERAPEUTICS, INC.
To: TEKV THERAPEUTICS, LLC
Reel/Frame 056949/0415 →
Change of Name Jul 22, 2021
From: KINETA ONE, LLC
To: KV1.3 THERAPEUTICS, LLC
Reel/Frame 057388/0017 →